MSD Global Health Innovation Fund
Corporate VCRahway · Series A–Late Stage · 10 people tracked
Find your way into MSD Global Health Innovation Fund
Sign up to find every way you can get introduced to MSD Global Health Innovation Fund
- Your email: who you already know at MSD Global Health Innovation Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MSD Global Health Innovation Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
MSD GHI Fund is a $600M evergreen corporate venture fund backing digital health and data-science companies that facilitate and optimize biopharmaceutical operations. It invests across stages: up to $2M in early-stage companies via its three accelerators (MSD Digital Science Studio, MSD IDEA Studios Singapore and Berlin), up to $10M at Series B/C, and more than $10M for growth capital tied to multiyear services contracts, taking up to 20-30% ownership. Investment focus spans drug discovery and clinical development, manufacturing/supply chain/IT, access to medicine and patient support, and real-world evidence generation. The fund invests globally with a focus on North America and Europe, offering strategic connections to MSD's global operations across 140+ countries.
Source: firm website, verified Oct 1, 2026.
Team · 10 people
from the firm's websiteWhat they invest in
from 32 of 41 portfolio companiesAI & Machine Learning ×23Digital Health ×21Healthtech ×19Biotech ×15Medical Devices ×10Deep Tech ×8SaaS ×8Data & Infrastructure ×4
HQs:United States×25United Kingdom×1
Investments · 41 tracked
founders shown can be your intro pathAeroSafe Global provides cold chain logistics and pharmaceutical distribution solutions through its proprietary "Cold Chain as a Service" model, serving specialty distributors, pharmaceutical manufacturers, health systems, specialty pharmacies, and direct-to-patient programs worldwide.
Circular EconomyHealthtechLogistics & Supply ChainSaaS
Co-investorsEndeavor CatalystEscalate Capital PartnersMerck Global Health Innovation FundWAVE Equity PartnersFlexstone Partners Pte. Ltd.Hamilton Lane
Aitia builds in silico models of human disease biology using a causal AI platform that combines multiomic and clinical patient data with supercomputing to support drug discovery and development.
AI & Machine LearningBiotechHealthtech
Co-investorsEcho Health VenturesMerck Global Health Innovation Fund
Arcadia provides a healthcare data platform that aggregates disparate sources such as EHRs, claims, and social determinants of health data, then applies analytics, AI, and automation to generate insights.
AI & Machine LearningDigital HealthHealthtech
Co-investorsEscalate Capital PartnersMerck Global Health Innovation FundRevelation Partners
Ash provides an end-to-end platform for at-home and in-person health testing, connecting organizations to a network of CLIA-/CAP-certified labs and licensed providers through a single integration.
Digital HealthHealthtechInsurTechMedical DevicesSaaSWellness & FitnessSilicon Valley, US
David Stein(Chief Executive Officer)inKyle Waters(Chief Product Officer)inMio AkasakoinNicolas SempereMatt Benton(Chief Financial Officer)inKiel Dowlin(Director)
Co-investors500 GlobalDorm RoomGeneral PartnershipMerck Global Health Innovation FundMerus CapitalXRC+3 more
Atropos Health develops a cloud-based platform that generates real-world evidence from electronic health records to inform clinical decision-making and healthcare research.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechStanford, US
Nigam Shah(Co-Founder & Chief Data Scientist)Brigham Hyde(Chief Executive Officer & co-Founder)inSaurabh Gombar(Chief Medical Officer & co-Founder)inNigam Shah, PhD MBBS(Co-Founder of Atropos Health & Chief Data Scientist at Stanford Health Care)NEIL SANGHAVI(Executive Officer)in
BoardMATTHEW BETTONVILLE(Director)
Co-investorsYosemiteBreyer CapitalCencora VenturesCerity Partners Venturesmark vcMcKesson Ventures+3 more
Baseimmune develops active immunotherapies using computational design and protein engineering to create custom antigens aimed at chronic diseases.
BiotechDeep TechHealthtechLondon, GB
Joshua Blight(Founder)inPhillip Kemloin
Co-investorsHoxton VenturesIQ CapitalCreator FundBeast VenturesMerck Global Health Innovation FundCherry Ventures+1 more
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Executive Officer, Director)inMark DePristo(Executive Officer, Director)in
BoardFrancisco Gimenez(Director)inSteve Kafka(Director)Vineeta Agarwala(Director)inRobert Chess(Director)
Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGRIDS CapitalMerck Global Health Innovation Fund+9 more
CancerIQ is a healthcare software platform that helps hospitals and providers run cancer risk-assessment and precision prevention programs by gathering patient data, triaging patients into risk tiers using guidelines like NCCN and Tyrer-Cuzick, and managing genetic counseling, testing, and ongoing care.
Digital HealthHealthtechSaaSChicago, US
Olufeyikemi Olopade Ayodele(Executive Officer, Director)Feyi Ayodele(Founder)inHaibo Lu(Executive Officer, Director)Christopher Bun(Executive Officer)Jordan Dolin(Director)Evan Wood(Director)
Co-investors2Flo VenturesCleveland AvenueHealthX VenturesLightbankMcKesson VenturesMerck Global Health Innovation Fund+2 more
CargoSense provides a SaaS cloud platform and services for supply chain exception management, offering real-time shipment visibility, sensor-based monitoring, and machine learning root cause analysis to detect and resolve logistics deviations.
AI & Machine LearningLogistics & Supply ChainSaaSReston, US
Richard A. C. Kilmer(Executive Officer, Director)inBenjamin Wilson(Executive Officer)Jeffrey Newman(Executive Officer)Mark Gardner(Executive Officer)inAjaipal S. Virdy(Director)
BoardMichael McNamara(Director)
Co-investorsArgonautic VenturesIrishAngelsMerck Global Health Innovation Fund
ClearDATA is a cloud security and compliance platform purpose-built for healthcare organizations.
Cloud ComputingCybersecurityDigital HealthHealthtech
Rick Froehlich(President & Chief Executive Officer)inJim Ducharme(Chief Technology Officer)inGregg Bjork(Chief Revenue Officer)inDrew Schaal(Chief Financial Officer)inCarol Boone(Vice President of People)in
Co-investorsExcel Venture ManagementFlare Capital PartnersMerck Global Health Innovation FundNorwest Venture PartnersHeritage GroupHLM Investment Partners
Datavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
Kyle Armbrester(Chief Executive Officer)in
Co-investorsFlex Capital PartnersGrand VenturesHealth Catalyst CapitalMerck Global Health Innovation FundOctaveSixth Street+3 more
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Founder and Board Director)inPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)inSusan Tousi(Chief Executive Officer)in
Co-investorsAV8 VenturesForesite CapitalIllumina VenturesInitiate Venture PartnersMenlo VenturesMerck Global Health Innovation Fund+7 more
Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab.
BiotechCloud ComputingDeep TechAustin, US
Brian Frezza(Founder)inD.J. Kleinbaum(Founder)in
Co-investorsAlumni VenturesBlue Ivy VenturesGigafundMerck Global Health Innovation FundSchooner CapitalSoundproof Ventures+2 more
ID Connect provides access to specialized infectious disease (ID) expertise through a team of clinicians and technology staff, using telemedicine to improve patient care and outcomes.
Digital HealthHealthtechMedical DevicesCranberry Township, US
John Mellors(Co-founder)Riaan Erwee(Executive Officer)Tami Minnier(Director)Rima Abdel-Massih(Co-founder)Brenton Burns(Director)Jonathan Phillips(Director)
Co-investorsMerck Global Health Innovation FundFirst Trust Capital Partners
Koneksa is a remote clinical evidence platform that enables studies across therapeutic areas using validated technology and comprehensive support services.
AI & Machine LearningBiotechDigital HealthMedical DevicesSaaS
Co-investorsMcKesson VenturesMerck Global Health Innovation FundWaterline Ventures
Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US
William Hagstrom(Founder and Chairman)inDoug Biehn(President and CEO)in
Co-investorsNorthpond VenturesSandbox IndustriesSection 32Blue Venture FundsEcho Health VenturesHikma Ventures+3 more
AI-powered pathology for improved patient outcomes
Boston, US
ANDREW BECK(Executive Officer, Director)inADITYA KHOSLA(Executive Officer, Director)
BoardMICHELLE DIPP(Director)STANLEY LAPIDUS(Director)inJEFF LEIDEN(Director)
Co-investors8VCBIOSPRING PARTNERSFairhaven Capital PartnersGeneral CatalystMerck Global Health Innovation FundNimble Partners+4 more
Computational microbiome analysis platform for immunologic disorders
Co-investors3CC | Third Culture CapitalGood AI CapitalHarmonix FundIaso VenturesJoyance PartnersMerck Global Health Innovation Fund+2 more
PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesNew York, US
Dr. Carlos Cordon-Cardo(Founder)Eric Converse(Chief Executive Officer and Director)inEdward Joseph Sitar(Chief Financial Officer)Wayne Brinster(Chief Executive Officer and Director)in
BoardErik Lium(Director)Westley Dupray(Director)
Co-investorsMerck Global Health Innovation FundPhilips Ventures
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in
BoardSean Kendall(Director)inMalek Faham(Director)in
Co-investorsARCH Venture PartnersIllumina VenturesMerck Global Health Innovation Fund
Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsCrane Venture PartnersHealthQuadLightspeed Venture PartnersMerck Global Health Innovation FundNVIDIAKae Capital+4 more
Redica offers an AI-enriched intelligence platform that unifies global regulatory, inspection, site, and post-market data to help companies manage risk and protect product quality.
AI & Machine LearningEnterprise SoftwareSaaSYorkville, US
Michael de la Torre(Executive Officer, Director)in
BoardJavier Rojas(Director)Rick Stratford(Director)inMartin Van Trieste(Director)Julian Castelli(Director)in
Co-investorsKennet PartnersMerck Global Health Innovation FundRock Creek Capital
Platform connecting healthcare providers with life science experts to access critical information and insights.
Co-investorsJavelin Venture PartnersMcKesson VenturesMerck Global Health Innovation FundSlater Technology FundSpectrum Equity
Saama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSCampbell, US
Suresh Katta(Executive Officer, Director)inSimon Ho(Executive Officer)in
BoardMarc McMorris(Director)inKen Coleman(Director)Dan Fishback(Director)William Binch(Director)
Co-investorsCarrick Capital PartnersMcKesson VenturesMerck Global Health Innovation FundPfizer Venture Investments
Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesAnn Arbor, US
Daniel Rhodes(Executive Officer, Director)Matthew Martin(Executive Officer)Jeffrey Williams(Executive Officer, Director)
BoardChristopher O'Donnell(Director)inDavid Rubin(Director)inJames Pavlik(Director)in
Co-investorsArboretum VenturesBaird CapitalMerck Global Health Innovation FundPfizer Venture InvestmentsDeerfield Management CompanyPfizer Ventures
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)inErwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)
BoardElizabeth Hambrecht(Director)Paul Conley(Director)in
Co-investorsForesite CapitalJ2 VenturesMerck Global Health Innovation FundOMX VenturesRA CapitalTechstars+3 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Chief Executive Officer)in
Co-investors7wire VenturesAlta PartnersCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint Ventures+6 more
Alexandria, US
Dennis Groseclose(Executive Officer, Director)Shariar Shahidi(Executive Officer)Dawn Morat(Executive Officer)James Clautice(Executive Officer)
BoardPatrick McPherson(Director)Joseph Volpe(Director)
Co-investorsMerck Global Health Innovation Fund
Turbine develops computational simulations of cells to accelerate drug discovery and development in oncology, using in silico predictions validated through wet lab experiments.
AI & Machine LearningBiotechDeep Tech
Szabolcs Nagy(Founder)in
Co-investorsAccelAlpha EdisonAtlanticBeiersdorf Innovation FundCrane Venture PartnersInteractive Venture Partners Llc+2 more
Unite Us provides software and data infrastructure for coordinating whole-person care, helping organizations identify social and health needs, deliver services, and track outcomes.
Digital HealthGovTechSaaSNew York, US
Daniel M. Brillman(Executive Officer)inTaylor Justice(Co-Founder and Chief Executive Officer)in
Co-investorsBlossom Street VenturesEqual Opportunity VenturesICONIQMerck Global Health Innovation FundMetafundOak HC/FT+9 more
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
BoardVasudev Bailey(Director)in
Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesDroia Ventures+7 more
Variational AI develops generative AI technology to accelerate small molecule drug discovery for pharmaceutical partners.
AI & Machine LearningBiotechDeep Tech
Handol Kim(Co-Founder & CEO)Jason Rolfe(Co-Founder & CTO)Ali Saberali(Co-Founder & Head of Platform)
Co-investorsFlying Fish VenturesMerck Global Health Innovation FundNimbus Synergies Inc.
Verana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSan Francisco, US
Mark Blumenkranz, MD(Co-Founder, Verana Health and Lagunita Biosciences)Sujay Jadhav(Chief Executive Officer)in
Co-investorsNovo HoldingsBreyer CapitalGV (Google Ventures)Merck Global Health Innovation FundNat TurnerTech Council Ventures+2 more
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(Co-founder & CEO)inJason Chen(Cofounder)inEmily Ripka(Head of Product & Engineering)in
Co-investorsAgent CapitalBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin Ventures+25 more
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in
BoardTerry Lierman(Director)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+2 more
Zephyr AI is a healthcare technology company.
AI & Machine LearningBiotechDigital HealthDallas, US
Grant Verstandig(Director)inYisroel Brumer(Director)Jeff Sherman(Executive Officer)David Morgan(Executive Officer)Ken Samet(Director)Sol Barer(Director)
Co-investorsMerck Global Health Innovation FundRed Cell IncubationRevolutionMedicxi
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EvaxionN-Power MedicineprognosTag-N-TracTriNetX
Portfolio news
latest coverage across their companiesUnnatural Products · finance.yahoo.com · Mar 16, 2026
Octave · finsmes.com · Sep 5, 2025
PreciseDx · finsmes.com · Jun 19, 2025
Redica Systems · finsmes.com · May 16, 2025
Frequently asked questions
- How many investments has MSD Global Health Innovation Fund made?
- MSD Global Health Innovation Fund has 41 tracked investments.
- What stage does MSD Global Health Innovation Fund invest at?
- MSD Global Health Innovation Fund invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is MSD Global Health Innovation Fund's typical check size?
- MSD Global Health Innovation Fund typically writes checks of $2M – $10M.
- What sectors does MSD Global Health Innovation Fund focus on?
- MSD Global Health Innovation Fund focuses on Biotech, Digital Health, Healthtech.
- Where is MSD Global Health Innovation Fund located?
- MSD Global Health Innovation Fund is headquartered in Rahway, US.
Images
Similar investors
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Optum Ventures is a healthcare-focused venture capital firm affiliated with UnitedHealth Group's Optum platform, investing in emerging healthcare and digital health companies across the US and globally.
Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.






























.jpeg)

























































.png)




































































.png)






























